Johnson & Johnson proposes $5.5bn US settlement over talc cancer claims
The proposed deal could resolve around 76,000 US ovarian cancer claims, but it does not affect the separate £1 billion group action working its way through the UK courts.
The proposed deal could resolve around 76,000 US ovarian cancer claims, but it does not affect the separate £1 billion group action working its way through the UK courts.
The High Court will rule on whether cases can be grouped into a single action and whether it should be fast-tracked as many claimants face serious illness.
Landmark UK legal action alleges asbestos-contaminated talc caused cancer in thousands has now been filed at the UK High Court. Have you been affected?
Pharmaceutical giant Johnson & Johnson is facing legal action in the UK over claims that its talcum powder products contained asbestos and caused cancer in thousands of people.
Group action law firm says around 100,000 people could have developed cancer after being exposed to asbestos in talcum powder.
Victims of the contaminated blood scandal are set to receive up to £2.7 million each with up to £15,000 extra for those subjected to ‘unethical’ research.